First AD

Second AD

Lung Cancer

JAN-22-OSD1275 - /clinical/lung-cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Expanding Horizons: Antibody Drug Conjugates in Non-Small Cell Lung Cancer

Insights

Drs Martin Dietrich and Wade Thomas Iams discuss the differences between the targets, payloads, and linker technologies of the antibody drug conjugates in development for lung cancer.

ADCs in Development for the Treatment of Lung Cancer

Overview of Antibody Drug Conjugates in Lung Cancer

Targeting CEACAM5 in Patients with Non-Small Cell Lung Cancer

HER2-Directed Agents in NSCLC

Targeting HER3 in EGFR-Mutant NSCLC

Exploring TROP2 Expression in Patients with NSCLC